2Purrell of Rabuzza AM.Metabolic factors that affect betacell function and survial [J] .Diabet Nutr Metab,2000,13:84-91.
3Diabetes control and complication trial research group(DCCT).The effect of intensive treatment of diabetes on the development and progression of longtime complication in insulin-dependent diabetes mellitus[J].N Engl Med,1993,329:977-986.
4UK Prospective Diabetes Study(UKPDS)Group.Intensive blood Glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patient with type 2 diabetes[J].Lancet,1998,352:837-853.
5Ilkova H,Glaser B,Tunckale A,et al Induction of long-term glycemic control in newly diagnosed type 2 diabetes patients by transient intensive insulin treatment[J].Diabetes Care ,1997,20:1353-1356.
6Bode Bw,Gross T,Steed RD ,et al,A recent assessment of continuation rates for continuous subcutaneous insulin infusion(CSⅡ)[J].Diabetes,1998,47(suppl 1):392.
2E. Torlone,C. Fanelli,A. M. Rambotti,G. Kassi,F. Modarelli,A. Vincenzo,L. Epifano,M. Ciofetta,S. Pampanelli,P. Brunetti,G. B. Bolli. Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM[J] 1994,Diabetologia(7):713～720
